# The CDKL5 kinase undergoes liquid–liquid phase separation driven by a serine-rich C-terminal region

**Authors:** Stefania Boggio Bozzo, Marco Dell’Oca, Serena Vaglietti, Antonia Gurgone, Vita Cardinale, Gregorio Ragazzini, Andrea Alessandrini, Luca Colnaghi, J Fernando Bazan, Mirella Ghirardi, Maurizio Giustetto, Ferdinando Fiumara

PMC · DOI: 10.26508/lsa.202503402 · 2026-03-10

## TL;DR

The CDKL5 protein forms cellular structures through a process called liquid–liquid phase separation, and mutations that shorten this protein may contribute to a neurodevelopmental disorder.

## Contribution

The study identifies a serine-rich region in CDKL5 responsible for liquid–liquid phase separation and links its loss to impaired function in a neurodevelopmental disorder.

## Key findings

- The C-terminal domain of CDKL5 drives liquid–liquid phase separation through a serine-rich region.
- Truncations in the C-terminal domain reduce CDKL5's ability to undergo phase separation and impair its function.
- Loss of phase separation capability in CDKL5 may contribute to the molecular basis of CDKL5 deficiency disorder.

## Abstract

This article uncovers the ability of the CDKL5 kinase to form intracellular condensates through liquid–liquid phase separation primarily mediated by a serine-rich low-complexity region. The loss of this region caused by neurodevelopmental disease-related mutations can alter CDKL5 localization and function.

The CDKL5 gene encodes a protein kinase involved in nervous system development and function. Pathogenic variants in this gene can cause a severe neurodevelopmental CDKL5 deficiency disorder (CDD). The CDKL5 protein contains a catalytic N-terminal domain (NTD) and a less characterized C-terminal domain (CTD). We discovered that the CTD is a serine-rich low-complexity region driving liquid–liquid phase separation (LLPS), a biophysical process controlling protein localization and function, by which CDKL5 forms intracellular membraneless condensates. A CTD internal fragment (CTIF) plays a pivotal LLPS-promoting role, along with the distal portion of the protein. In CDD, transcripts carrying pathogenic nonsense or frameshift mutations introducing distal premature termination codons may escape nonsense-mediated decay, producing CDKL5 proteins with a variably truncated CTD. We found that two distal truncations, removing part of the CTIF and the downstream protein tail, significantly reduce CDKL5 LLPS and catalytic function. These findings demonstrate that CDKL5 undergoes LLPS, driven by a CTD region whose loss in distally truncated forms of the protein—by impairing LLPS and functional activity—may play a role in the molecular pathogenesis of CDD.

## Linked entities

- **Genes:** CDKL5 (cyclin dependent kinase like 5) [NCBI Gene 6792]
- **Proteins:** CDKL5 (cyclin dependent kinase like 5)
- **Diseases:** CDKL5 deficiency disorder (MONDO:0100039), CDD (MONDO:0009031)

## Full-text entities

- **Genes:** CDKL4 (cyclin dependent kinase like 4) [NCBI Gene 344387], AARS1 (alanyl-tRNA synthetase 1) [NCBI Gene 16] {aka AARS, CMT2N, DEE29, EIEE29, HDLS2, TTD8}, SYP (synaptophysin) [NCBI Gene 6855] {aka MRX96, MRXSYP, XLID96}, FUZ (fuzzy planar cell polarity protein) [NCBI Gene 80199] {aka CPLANE3, FY, NTD}, NEAT1 (nuclear paraspeckle assembly transcript 1) [NCBI Gene 283131] {aka LINC00084, NCRNA00084, TP53LC15, TncRNA, VINC}, CTIF (cap binding complex dependent translation initiation factor) [NCBI Gene 9811] {aka Gm672, KIAA0427}, CRY2 (cryptochrome 2) [NCBI Gene 839529] {aka AT-PHH1, ATCRY2, CRYPTOCHROME 2 APOPROTEIN, F19P19.14, F19P19_14, FHA}, TARDBP (TAR DNA binding protein) [NCBI Gene 23435] {aka ALS10, TDP-43}, MECP2 (methyl-CpG binding protein 2) [NCBI Gene 4204] {aka AUTSX3, MRX16, MRX79, MRXS13, MRXSL, PPMX}, CILK1 (ciliogenesis associated kinase 1) [NCBI Gene 22858] {aka CED6, ECO, EJM10, ICK, LCK2, MRK}, CDKL1 (cyclin dependent kinase like 1) [NCBI Gene 8814] {aka KKIALRE, P42}, PMCH (pro-melanin concentrating hormone) [NCBI Gene 5367] {aka MCH, ppMCH}, FLT3LG (fms related receptor tyrosine kinase 3 ligand) [NCBI Gene 2323] {aka FL, FLG3L, FLT3L, IMD125}, PDP1 (pyruvate dehydrogenase phosphatase catalytic subunit 1) [NCBI Gene 54704] {aka PDH, PDP, PDPC, PDPC 1, PPM2A, PPM2C}, CDKL2 (cyclin dependent kinase like 2) [NCBI Gene 8999] {aka KKIAMRE, P56}, Cdkl5 (cyclin dependent kinase like 5) [NCBI Gene 382253] {aka Stk9}, CDKL3 (cyclin dependent kinase like 3) [NCBI Gene 51265] {aka NKIAMRE}, CTD (Coats disease) [NCBI Gene 1283], CDKL5 (cyclin dependent kinase like 5) [NCBI Gene 6792] {aka CFAP247, DEE2, EIEE2, ISSX, STK9}, VCL (vinculin) [NCBI Gene 7414] {aka CMD1W, CMH15, HEL114, MV, MVCL, VINC}
- **Diseases:** epileptic encephalopathy (MESH:D001927), RTT (MESH:D015518), neurodevelopmental disease (MESH:D004194), CDD (MESH:C538124), neurocognitive impairment (MESH:D019965), phototoxicity (MESH:D017484), West syndrome (MESH:D013036), CDD (MESH:C564064), LLPS (MESH:D000210), neurodevelopmental disorders (MESH:D002658), seizures (MESH:D012640)
- **Chemicals:** penicillin (MESH:D010406), glycerol (MESH:D005990), Hepes (MESH:D006531), phalloidin (MESH:D010590), K (MESH:D011188), S (MESH:D013455), NaCl (MESH:D012965), AF-488 (-), MgCl2 (MESH:D015636), carbon (MESH:D002244), streptomycin (MESH:D013307), epoxy resin (MESH:D004853), Alexa Fluor 488 (MESH:C000711379), alanine (MESH:D000409), oil (MESH:D009821), polyS (MESH:C027794), uranyl acetate (MESH:C005460), Triton X-100 (MESH:D017830), serine (MESH:D012694), EDTA (MESH:D004492), Hoechst 33342 (MESH:C017807), amino acid (MESH:D000596), N (MESH:D009584), NP-40 (MESH:C010615), 1,6-Hexanediol (MESH:C027765), Lipofectamine (MESH:C086724), PMSF (MESH:D010664), sodium fluoride (MESH:D012969), CMXRos (MESH:C107472), TBS (MESH:D013725), agarose (MESH:D012685), CO2 (MESH:D002245), L-glutamine (MESH:D005973), cacodylate (MESH:D002101), E (MESH:D004540), L (MESH:D007930), water (MESH:D014867), osmium (MESH:D009992), dbcAMP (MESH:D003994), ethanol (MESH:D000431), DAPI (MESH:C007293), asparagine (MESH:D001216), PVDF (MESH:C024865), copper (MESH:D003300), SDS (MESH:D012967), glutamate (MESH:D018698), glutaraldehyde (MESH:D005976), lysine (MESH:D008239), potassium ferrocyanide (MESH:C031835), PBS (MESH:D007854), DTT (MESH:D004229), Tween-20 (MESH:D011136), TBS-T (MESH:C027647)
- **Species:** Danio rerio (leopard danio, species) [taxon 7955], Arabidopsis thaliana (mouse-ear cress, species) [taxon 3702], Anolis carolinensis (Carolina anole, species) [taxon 28377], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090], Caenorhabditis elegans (species) [taxon 6239], Rattus norvegicus (brown rat, species) [taxon 10116], Bos taurus (bovine, species) [taxon 9913], Xenopus laevis (African clawed frog, species) [taxon 8355], Drosophila melanogaster (fruit fly, species) [taxon 7227], Petromyzon marinus (marine lamprey, species) [taxon 7757], C. elegans [taxon 328850]
- **Mutations:** V718M, alanine/glutamine, R781X, T958R, S781X, 726X, r.2047_2152del, c.2152G>A, L120C, asparagine/serine, S726X, 781X, A to Y
- **Cell lines:** NG1081-15 — Homo sapiens (Human), Pleural epithelioid mesothelioma, Cancer cell line (CVCL_M193), NG108-15 — Mus musculus (Mouse), Hybrid cell line (CVCL_0464), 293-F — Homo sapiens (Human), Transformed cell line (CVCL_6642), HEK293 — Homo sapiens (Human), Transformed cell line (CVCL_0045)

## Figures

15 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12976563/full.md

---
Source: https://tomesphere.com/paper/PMC12976563